The Investment Column: Business as usual at Amersham
Wednesday 12 November 1997
Since the Norwegian tie-up was announced in early July, shares in Amersham have soared by a third. Yesterday's first results since that deal - interims from Amersham and third quarters from Nycomed - pushed the price up another 27.5p to 2222.5p.
The numbers themselves offer no real guide to the shape of the new company. The Nycomed deal was only cemented two and a half weeks ago and chief Bill Castell says it is too early to confirm estimates of pounds 40m a year cost savings. What the numbers did do is reassure that, despite the deal, it is business as usual for both companies.
Amersham's new Pharmacia business, supplying chemicals used in drug company research, looks a good buy. In just two months it contributed pounds 6m, driving sales in the half year at Amersham's Life Science division 65 per cent ahead to pounds 122m at constant currency and profits 55 per cent ahead to pounds 22m. Cost savings of pounds 30m a year over a three-year period should be possible.
On the Healthcare side, even excluding acquisitions, profits rose 58 per cent, driven by growing demand for Myoview, the heart-imaging agent, and the iodine seed treatment for prostate cancer.
Integrating Nycomed will be a big and potentially disruptive job, though Mr Castell insists morale is high. Commercially the acquisition makes great sense, giving Amersham a full range of imaging agents and innovations like ultrasound. Concern over price pressure in Nycomed's core US contrast media agent business remain, though Nycomed's cost reduction plan looks on track. At current levels, the shares trade on over 20 times earnings. Until the group presents integrated figures next March, that looks high enough, particularly given the inevitable disruption associated with a large merger.
- 1 Woman falls to her death as she celebrates marriage proposal at the edge of Ibiza cliff
- 2 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 3 Dad attempts revenge on teenage daughter, plan backfires spectacularly
- 4 Ball pool for adults opens in London
- 5 Amal Clooney gives excellent response to fashion question at European Court of Human Rights
Isis 'throw man off a building for homosexual affair' and beat him to death when he survives
Woman falls to her death as she celebrates marriage proposal at the edge of Ibiza cliff
Boris Johnson claims porn-obsessed Islamic jihadists are 'literally w*****s'
Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
Ball pool for adults opens in London
9 reasons Greece's experiment with the radical left is doomed to failure
Have we reached 'peak food'? Shortages loom as global production rates slow
Greece elections: Syriza and EU on collision course after election win for left-wing party
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
Liberal Democrat minister defends comments suggesting immigration causes pub closures
King Abdullah dead: We can't afford not to hold Saudi Arabia's royals to account
iJobs Money & Business
£40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...
£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...
£13000 per annum: Recruitment Genius: This Pension Specialist was established ...
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...